Biomarkers of eosinophilic inflammation

Celeste Porsbjerg, Unnur Björnsdóttir

Source: Eur Respir Monogr 2022; 95: 37-50

Congress or journal article abstractFull text journal article

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Celeste Porsbjerg, Unnur Björnsdóttir. Biomarkers of eosinophilic inflammation. Eur Respir Monogr 2022; 95: 37-50

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Possible role of IL-25 in eosinophilic lung inflammation in patients with eosinophilic pneumonia
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017


Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease
Source: Eur Respir Monogr 2022; 95: 219-237
Year: 2022


Modulation of Eosinophilic airway inflammation in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005

Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (5) 2000622; 10.1183/13993003.00622-2020
Year: 2020



Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (6) 2004167; 10.1183/13993003.04167-2020
Year: 2020



Stability of eosinophilic inflammation in COPD bronchial biopsies
Source: Eur Respir J, 56 (6) 2003802; 10.1183/13993003.03802-2020
Year: 2020



Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013


Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Eicosanoids and eosinophilic inflammation of airways in stable COPD.
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


Bronchial hyper-responsiveness in chronic eosinophilic pneumonia is not correlated uniquely to local eosinophil infiltration
Source: Eur Respir J 2002; 20: Suppl. 38, 315s
Year: 2002

The pathological feature of airway inflammation in eosinophilic bronchitis
Source: Eur Respir J 2005; 26: Suppl. 49, 282s
Year: 2005

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthma
Source: Annual Congress 2011 - Phenotyping airway diseases
Year: 2011


Apoptotic response of eosinophils in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 17: 190-194
Year: 2001



Eosinophilic inflammation and asthma control
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

Imaging of eosinophilic lung disease
Source: Eur Respir Monogr 2022; 95: 51-72
Year: 2022


Acceleration of neutrophilic inflammation during COPD exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002

Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


Biological role of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019

Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015